TCL Archive Abraxane-Gemcitabine Combination Extends Overall Survival in Phase III Trial January 31, 2014
TCL Archive In Brief: DOD Bill includes $135M For breast Cancer, $45M For prostate Cancer Technologies October 3, 1997
TCL Archive Progress Toward Year 2000 Goal Slow, But NCAB Says It’s Too Early, Only Data Up To ’87 Available January 5, 1990